We proudly celebrate our 23rd birthday, celebrating innovation, collaboration and scientific excellence that Pharmidex has helped create!
May 19, 2025
Since 2002,
Pharmidex has grown into a trusted partner in preclinical drug discovery and development, contributing to over 16,000 studies across therapeutic areas including CNS, immunology, oncology, respiratory and stroke.
We’re proud to be AAALAC- and MHRA-accredited, providing high-quality GLP and GCP-compliant services that have supported clients across biotech, pharma, and academia worldwide.
Our integrated expertise in Clinical Pathology, DMPK, ADMET, Pharmacokinetics, Toxicology and BBB penetration studies continues to shape the success of early-stage drug candidates.
💡 As we commemorate this milestone, we reflect on:
✔ The dedication of our exceptional team
✔ The trust and collaboration of our partners and clients
✔ Our continued mission to advance science and improve lives
Here’s to 23 years of impact and many more to come!
#Pharmidex23 #DrugDiscovery #PharmaceuticalInnovation #CRO #DMPK #OncologyResearch #CNS #PreclinicalResearch #TeamPharmidex
Our Head of Integrated Therapeutics and CNS, Dr. Stephen Mitchell , our Business Development Manager, Janette Dalay Robertson and our Senior Research Scientist in CNS, Jewel Ahmed will be there to engage with attendees, share insights and explore new collaborations driving innovation in Parkinson’s disease drug discovery and development. If you’re attending, don’t hesitate to reach out, they’ll be delighted to connect and discuss how Pharmidex’s integrated expertise can help move your research from concept to clinic.
We are delighted to share that Prof. Mo Alavijeh will be attending the upcoming 🔬 OBN (UK) Ltd BioTuesday: A Spotlight on the Latest R&D for the Diagnosis & Treatment of Prostate Cancer 📅 11 November 2025 📍 Ipsen, Paddington, London This event brings together leading experts and innovators shaping the future of prostate cancer research and therapy. If you’re attending, don’t miss the opportunity to meet with Prof. Mo Alavijeh (FRSC, FRSM), and explore how collaboration can accelerate progress in drug discovery and development.
Pharmidex is looking for an experienced and motivated Technical Specialist to join our Bioanalytical team . You’ll play a key role in developing and delivering high-quality LC-MS bioanalytical methods supporting both small and large molecule programmes, including peptides and oligonucleotides. We’re seeking someone with: 🔹 5+ years of hands-on LC-MS/MS experience 🔹 Proven method development & validation expertise 🔹 Strong understanding of regulated bioanalysis (GLP/GCP) 🔹 CRO experience (preferred) At Pharmidex, you’ll collaborate with talented scientists across diverse therapeutic areas, working on innovative discovery and preclinical studies. If you’re passionate about bioanalysis, science, and innovation, we’d love to hear from you. 👉 Apply now via www.pharmidex.com/careers or message us directly for more details.
